Skip to content
You are not logged in |Login  
     
Limit search to available items
Record 6 of 26
Previous Record Next Record
Book Cover
book
BookBook
Author Carreyrou, John, author.

Title Bad blood : secrets and lies in a Silicon Valley startup / John Carreyrou.

Publication Info. New York : Alfred A. Knopf, 2018.
©2018
1 hold on first copy returned of 37 copies

Copies

Location Call No. Status
 Avon Free Public Library - Adult Display Shelf  338.761 CARREYROU    DUE 05-17-24
 Berlin-Peck Memorial Library - Non Fiction  338.761 CARREYROU    Check Shelf
 Bloomfield, Prosser Library - Adult Department  338.7 CAR    Storage
 Bristol, Main Library - Non Fiction  338.7681 CARREYROU    Check Shelf
 Burlington Public Library - Adult Department  338.7681 CAR    Check Shelf
 Canton Public Library - Adult Department  338.7681 CARREYROU    Check Shelf
 Cheshire Public Library - Adult Department Lower Level  338.7681 CARREYROU    Check Shelf
 Cromwell-Belden Public Library - Adult Department  338.7681 CAR    Check Shelf
 East Hartford, Raymond Library - Adult Department  338.7 CARREYROU    Check Shelf
 Enfield, Main Library - Adult Department  338.7 CAR    Check Shelf

Edition First edition.
Description x, 339 pages ; 25 cm
Bibliography Includes bibliographical references (page [305]-324) and index.
Contents A purposeful life -- The gluebot -- Apple envy -- Goodbye East Paly -- The childhood neighbor -- Sunny -- Dr. J -- The miniLab -- The wellness play -- "Who is LTC Shoemaker?" -- Lighting a Fuisz -- Ian Gibbons -- Chiat\Day -- Going live -- Unicorn -- The grandson -- Fame -- The Hippocratic Oath -- The tip -- The ambush -- Trade secrets -- La mattanza -- Damage control -- The empress has no clothes -- Epilogue.
Summary In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When John Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors.
Subject Holmes, Elizabeth Anne, 1984-
Theranos (Firm) -- History.
Hematologic equipment industry -- United States.
New business enterprises -- Corrupt practices -- United States -- Case studies.
Securities fraud -- United States -- Case studies.
Fraud -- United States.
Businesspeople -- United States.
BUSINESS & ECONOMICS / Entrepreneurship.
BUSINESS & ECONOMICS / Finance.
TECHNOLOGY & ENGINEERING / Biomedical.
Fraud. (OCoLC)fst00933786
Hematologic equipment industry. (OCoLC)fst00954898
United States. (OCoLC)fst01204155
Genre/Form History. (OCoLC)fst01411628
Added Title Secrets and lies in a Silicon Valley startup
ISBN 9781524731656 (hardcover)
152473165X (hardcover)
-->
Add a Review